Understand treatment parameters for CLL/SLL |
|
|
|
|
|
Understand similarities/differences between MBL/CLL/SLL |
|
|
|
|
|
Understand high risk vs low risk CLL/SLL and associated best treatments based on these findings |
|
|
|
|
|
Emphasize the importance of testing for IGHV status and clinical implications |
|
|
|
|
|
Understand common treatment options with focus on shifting away from CIT for many patients given success of novel therapies (oral agents and immunotherapies) |
|
|
|
|
|